SARS-CoV-2 Immunohistochemistry In Placenta

2021 ◽  
pp. 106689692110677
Author(s):  
Dinesh Rakheja ◽  
Kristina Treat ◽  
Charles F. Timmons ◽  
Deyssy Carrillo ◽  
Sara E. Miller ◽  
...  

Compared to the parental SARS-CoV-2 virus, infections by the now dominant Delta variant of SARS-CoV-2 appear to be more common and more severe in pregnant women. The need for a robust, cheap, and quick method for diagnosing placental infection by SARS-CoV-2 has thus become more acute. Here, we describe a highly sensitive and specific immunohistochemical assay for SARS-CoV-2 nucleocapsid protein for routine use in placental pathology practice.

Heliyon ◽  
2021 ◽  
pp. e06393
Author(s):  
Irina Oltean ◽  
Jason Tran ◽  
Sarah Lawrence ◽  
Brittany Ann Ruschkowski ◽  
Na Zeng ◽  
...  

2021 ◽  
pp. 109352662110251
Author(s):  
James Roberts ◽  
Jeanette D Cheng ◽  
Elizabeth Moore ◽  
Carla Ransom ◽  
Minhui Ma ◽  
...  

Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age placenta with extensive intervillous histiocytosis, syncytiotrophoblast karyorrhexis, and diffuse intervillous fibrin deposition. Immunohistochemical staining demonstrated infection of the syncytiotrophoblasts by SARS-CoV-2 inversely related to the presence of intervillous histiocytes and fibrin deposition. Our case demonstrates that despite extensive placental pathology, no fetal transmission of SARS-CoV-2 occurred, as well as postulates a relationship between placental infection, inflammation, and fibrin deposition.


PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e80346 ◽  
Author(s):  
Alexandra Ducancelle ◽  
Pierre Abgueguen ◽  
Jacques Birguel ◽  
Wael Mansour ◽  
Adeline Pivert ◽  
...  

2017 ◽  
Vol 125 (1) ◽  
pp. 134-140 ◽  
Author(s):  
Blair J. Wylie ◽  
Emmanuel Matechi ◽  
Yahya Kishashu ◽  
Wafaie Fawzi ◽  
Zul Premji ◽  
...  

2016 ◽  
Vol 214 (1) ◽  
pp. S316 ◽  
Author(s):  
Blair J. Wylie ◽  
Emmanuel Matechi ◽  
Yahya Kishashu ◽  
Wafaie Fawzi ◽  
Brent Coull ◽  
...  

2020 ◽  
Vol 319 (2) ◽  
pp. E315-E319 ◽  
Author(s):  
Thea N. Golden ◽  
Rebecca A. Simmons

The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to maternal and newborn health has yet to be determined. Several reports suggest pregnancy does not typically increase the severity of maternal disease; however, cases of preeclampsia and preterm birth have been infrequently reported. Reports of placental infection and vertical transmission are rare. Interestingly, despite lack of SARS-CoV-2 placenta infection, there are several reports of significant abnormalities in placenta morphology. Continued research on pregnant women infected with SARS-CoV-2 and their offspring is vitally important.


2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Eleanor R. Turnbull ◽  
Nzali G. Kancheya ◽  
Jennifer B. Harris ◽  
Stephanie M. Topp ◽  
German Henostroza ◽  
...  

Timely diagnosis and treatment of maternal tuberculosis (TB) is important to reduce morbidity and mortality for both the mother and child, particularly in women who are coinfected with HIV. The World Health Organization (WHO) recommends the integration of TB/HIV screening into antenatal services but available diagnostic tools are slow and insensitive, resulting in delays in treatment initiation. Recently the WHO endorsed Xpert MTB/RIF, a highly sensitive, real-time PCR assay forMycobacterium tuberculosisthat simultaneously detects rifampicin resistance directly from sputum and provides results within 100 minutes. We propose a model for same-day TB screening and diagnosis of all pregnant women at antenatal care using Xpert MTB/RIF. Pilot studies are urgently required to evaluate strategies for the integration of TB screening into antenatal clinics using new diagnostic technologies.


Sign in / Sign up

Export Citation Format

Share Document